For example, rituximab, an anti-CD20 monoclonal antibody, induces senescence in B cell lymphoma, manifested as increased SA-β-gal expression, p21/p53 signaling, and elaboration of a SASP (80, 140). The gene discussed is TP53; the disease is B-cell non-Hodgkin lymphoma.